Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alfacell (ACEL) -- Ignore unavailable to you. Want to Upgrade?

To: David Cathcart who wrote (1375)	6/11/1998 10:19:00 AM
From: Greg Kevorkian	Read Replies (1) \| Respond to of 1533

I believe that the ability to present the data is a strong point for the company. They have done well going from PI to P2 to P3 and I have confidence that they will present well. Does anyone know if the pre-meeting with the FDA is a public meeting. As John has stated, all the research and info I get supports good data. If we just mimic P2 data we should have no difficulty with the NDA. BUT, the silence is killing us and the stock. I know several people who have called the company and have gotten ther response of "No Comment' to various question concerning Data and Agreements. G